In his opening remarks, Minister Champagne talked about the suitability for COVID-19 vaccine production. Even among those existing vaccine producers in Canada, he said the capacity is already allocated for some of the flu vaccine.
I have two questions. Number one, what would be considered suitable COVID-19 vaccine production? What qualifies, or what is unique about that? As part of either the vaccine task force or the Joint Biomanufacturing Subcommittee, did we explore working with those existing facilities to expand their capacity?